Navigation Links
New Science Education Program Responds to President's Call to Help Young People Excel in Science

DEERFIELD, Ill., May 3 /PRNewswire/ -- Today Astellas Pharma US, Inc. ("Astellas") announced the launch of "Science WoRx," a program designed to help science teachers inspire the next generation of scientists. The program features a hands-on education and mentoring program, an online resource portal and online networking communities. In addition, Science WoRx is hosting a competition, "Make My LabWoRx," inviting science teachers to submit their favorite original lesson plans for a chance to win lab equipment for their school.

Astellas' announcement follows the launch of President Obama's "Educate to Innovate" campaign, which signals a significant unmet need to improve students' performance in science, technology, engineering and mathematics (STEM) subjects. Recent studies reveal that U.S. students are trailing behind other developed countries in science literacy. In the latest Programme for International Student Assessment (PISA) comparison study, U.S. students ranked 21st out of 30 in science literacy among developed countries.(1)  

In addition, according to the Lemelsen-MIT Invention Index, approximately one-third of teens indicate that they are discouraged from pursuing a career in STEM fields because they do not know anyone who works in these fields or understand what people in these fields do.(2)

"Science WoRx was developed to address the critical need for more resources in the classroom. The future Nobel Laureates in chemistry and medicine are sitting in our classrooms," said Seigo Kashii, president and CEO of Astellas Pharma US, Inc. "Our hope is that Science WoRx will provide teachers with the support they need to help prepare the world's pipeline of future scientists."

A core component of Science WoRx is Science Pro, a Chicago-area, hands-on education and mentoring program that connects Astellas scientists with students in the classroom through live demonstrations on human health and science. To fully engage students, the Science Pros illustrate how the scientific method applies to everyday, practical situations and solutions.

"My interest in science began when I was a child. I am an example of the tremendous potential that science teachers have to inspire their students and create a lifelong interest in the subject," says Dr. Robert Kernstock, Principal Scientist, Clinical Pharmacology & Translational Science and Astellas Science Pro. "I'm thrilled to have the opportunity to support our local science teachers through Science WoRx, and take part in encouraging the next generation of scientists."  

In addition to Science Pro, Science WoRx offers teachers nationwide an online resource portal – – where science educators can find valuable information on human health and medicine and access resources from leading science education partners National Science Teachers Association (NSTA) and iBIO Institute, including lesson plans and classroom instruction resources. Digitally savvy teachers may join the Science WoRx online communities including Twitter and Facebook to connect with peers, exchange insights and learn about the latest science breakthroughs.

Headquartered in Deerfield, IL, Astellas' creation of the Science WoRx program in the U.S. represents one of the key initiatives the company is undertaking to support science education. Astellas has a longstanding tradition of support for science education, and is entering its third year of support for the NSTA's New Science Teacher Academy by sponsoring 15 local area science teachers to participate in the national, year-long professional development initiative. The program promotes quality science teaching by connecting new science teachers to a range of tools and resources, while providing the essential support needed to build a strong foundation for science in their classrooms.

For more information, teachers can visit, and Science WoRx on Twitter @ScienceWoRx.

About Astellas

Astellas' culture and brand is committed to building community, helping others, encouraging integrity and inspiring people to make a difference, today, tomorrow and every day. Astellas Pharma US, Inc., located in Deerfield, Illinois, is a U.S. affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organization is committed to becoming a global category leader in focused areas by combining outstanding R&D and marketing capabilities. In the U.S., Astellas markets products in the areas of Anti-Infectives, Cardiology, Dermatology, Neuroscience, Transplant, and Urology. For more information about Astellas Pharma US, Inc., please visit our website at

(1) Organisation for Economic Co-operation and Development, Programme for International Student Assessment (PISA): Science Competencies for Tomorrow's World, 2006. Available at:,3343,en_32252351_32236191_39718850_1_1_1_1,00.html

(2) Massachusetts Institute of Technology 2009 Lemelsen-MIT Invention Index, MIT News "Teens prepared for math, science careers, yet lack mentors" January 7, 2009.

SOURCE Astellas Pharma US, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
2. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
3. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
4. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
5. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
6. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
7. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
8. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
9. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
10. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
(Date:12/1/2015)... SAN FRANCISCO , Dec. 1, 2015  InCarda ... the development and commercialization of therapies for cardiovascular conditions ... established a subsidiary business in Australia ... clinical trial in Australia in ... with leading investigators and medical centers in ...
(Date:12/1/2015)... SALT LAKE CITY , Dec. 1, 2015  Booth ... at booth #3506 during the annual meeting of the Radiological ... Chicago this year. Based in ... Imaging Components business of Varian Medical Systems (NYSE: VAR ... high voltage connectors, ionization chambers and solid state automatic exposure ...
(Date:12/1/2015)... -- Olea Sensor Networks, a leader in intelligent sensors and analytic software for sensor network-based systems, ... real-time data collection of vital signs. Photo ... ... ... ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... ... continuing medical education (CME), today announced that the first annual School of Gastrointestinal ... , “The prevention, detection and treatment of gastrointestinal cancers are undergoing transformational change, ...
(Date:12/1/2015)... ... 01, 2015 , ... Speech and physical therapies are traditionally ... technologies and under the right circumstances, these practices can be merged. This ... to his or her therapeutic sessions, as well as gives the physical and ...
(Date:12/1/2015)... ... December 01, 2015 , ... CloudLIMS ... 2015 Golden Bridge Business Awards under the New Products and Services category for ... based sample management software that helps labs organize data and track ...
(Date:12/1/2015)... CHICAGO (PRWEB) , ... December 01, 2015 , ... ... risk quantification and optimization of adjunctive imaging is the focus of numerous abstracts ... (RSNA) meeting, November 29-December 4, 2015. Nine abstracts highlight the use of ...
(Date:12/1/2015)... ... 01, 2015 , ... SAN FRANCISCO, Calif. (December 1, 2015) ... has awarded Education and Developmental Therapies (EDT), an Applied Behavior Analysis (ABA) service ... special needs providers that excel in synthesizing the areas of clinical quality, staff ...
Breaking Medicine News(10 mins):